Marcel Brown | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Dr. Marcel Brown | Medicine and Dentistry | Research Excellence Award

Atrium Health Wake Forest Baptist | United States

Dr. Marcel Brown is a clinician–scientist whose research portfolio integrates orthopaedic surgery, regenerative medicine, translational molecular science, and cardiovascular physiology, with a strong emphasis on clinically impactful, mechanism-driven investigation. His scholarly output comprises 7 peer-reviewed documents, which have collectively received 145 citations, reflecting an h-index of 3, indicative of consistent citation impact across his publications. His research experience spans advanced orthopaedic outcomes research, musculoskeletal infection prevention, stem cell and acellular biologic therapies for osteoarthritis and post-traumatic osteoarthritis, and translational studies evaluating tissue regeneration, inflammation, and functional recovery using in vitro, in vivo, and ex vivo models. Complementing this work, he has contributed substantially to cardiovascular and exercise physiology research, including investigations into exercise-induced cardiac remodeling, pulmonary vascular disease, metabolic and hormonal responses to physical stress, and molecular mechanisms underlying maladaptive vascular fibrosis. His interdisciplinary collaborations have resulted in publications across high-impact journals in orthopaedics, translational medicine, cardiovascular science, and cell biology, including original research articles, systematic analyses, and clinically relevant case reports. Collectively, his research demonstrates a sustained commitment to bridging basic science with clinical application, advancing evidence-based surgical practice, regenerative strategies, and cardiometabolic health through rigorously designed translational and outcomes-focused studies.

 

Citation Metrics (Scopus)

150120

90

60

30

0

Citations
145

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Risk factors for failure after lumbar tubular microdecompression without stabilization
– Journal of the American Academy of Orthopaedic Surgeons, 2025

Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Prof. Dr. Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Soonchunhyang University | South Korea

Prof. Dr. Keon-Hyoung Song is a distinguished researcher whose work bridges pharmaceutical sciences, drug delivery systems, and pharmacokinetics. With 708 citations, 27 scholarly publications, and an h-index of 13, his research has significantly advanced the understanding of membrane permeation enhancers, drug formulation, and solubilization strategies. His extensive portfolio includes high-impact studies on intestinal absorption mechanisms, cocrystal engineering, and pharmacokinetic optimization, published in reputed journals such as Pharmaceutics, European Journal of Medicinal Chemistry, and Journal of Controlled Release. Prof. Song’s innovations extend beyond academia, with over 25 international patents registered across the U.S., Europe, and Korea, focusing on permeation-enhancing peptides, liposomal carriers, and pharmaceutical formulations. His pioneering patents, including those on mucous membrane permeation peptides (EP 3875103, 2025) and sugar alcohol-based liposome compositions, underscore his role in translating laboratory discoveries into therapeutic applications. Licensed as both a Patent Attorney and a Pharmacist, he effectively integrates regulatory insight with scientific innovation. Prof. Song’s sustained contributions to quantitative drug analysis using LC-MS and formulation optimization have made him a leading figure in advancing next-generation drug delivery technologies and pharmaceutical development.

Profile : Scopus

Featured Publications

Jeong, D.-H., Kim, J.-W., & Song, K.-H. (2025). Improved intestinal permeation of cyclosporin A by FCIGRL-modified tight junction modulator in rats. Pharmaceutics, 17(11), 1395.

Park, G., Galdamez, A., Song, K.-H., Le, M., Kim, K., & Lin, J. H. (2024). Ethnic variation and structure–function analysis of tauopathy-associated PERK alleles. Israel Journal of Chemistry, 64(12).

Song, K.-H. (2024). Effect of tight junction-modulating FCIGRL-modified peptides on the intestinal absorption of doxorubicin in rats. Pharmaceutics, 16(5), 650.

Jiang, F.-L., Jeong, D.-H., Eom, S.-H., Lee, H.-M., Cha, B.-J., Park, J.-S., Kwon, R.-K., Nam, J.-Y., Yu, H.-S., Heo, S.-H., Kim, C.-H., & Song, K.-H. (2024). Effects of enteric-coated formulation of sodium bicarbonate on bicarbonate absorption and gastrointestinal discomfort. Nutrients, 16(5), 744.

Koo, N. R., Yoon, S., Song, K.-H., Baek, M. J., Jeon, S., & Im, J. (2024). Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy. European Journal of Medicinal Chemistry, 265, 116050.

Park, G., Xu, K., Chea, L., Kim, K., Safarta, L., Song, K.-H., Wu, J., Park, S., Min, H., Hiramatsu, N., Han, J., & Lin, J. H. (2023). Neurodegeneration risk factor EIF2AK3 (PERK) influences tau protein aggregation. The Journal of Biological Chemistry, 299(2), 102821.

Eom, Y. S., Jeong, D., Ryu, A.-R., Song, K.-H., Im, D. S., & Lee, M.-Y. (2022). Daphne odora exerts depigmenting effects via inhibiting CREB/MITF and activating AKT/ERK-signaling pathways. Current Issues in Molecular Biology, 44(8), 3312–3323.

Kim, H., Song, K.-H., Ambegaonkar, J. P., Chung, S., Jeon, K., Jiang, F. L., Eom, J. J., & Kim, C.-H. (2022). Two-megahertz impedance index prediction equation for appendicular lean mass in Korean older people. BMC Geriatrics, 22(1), 385.

Jiang, F., Tang, S., Eom, J.-J., Song, K.-H., Kim, H., Chung, S., & Kim, C.-H. (2022). Accuracy of estimated bioimpedance parameters with octapolar segmental bioimpedance analysis. Sensors, 22(7), 2681.

Yoon, Y. M., Lee, J. H., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. Journal of Pineal Research, 68(3), e12632.

Lee, J. H., Yoon, Y. M., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway. Aging Cell, 19(3), e13111.

Cha, S. J., Choi, H.-J., Kim, H.-J., Choi, E. J., Song, K.-H., Im, D. S., & Kim, K. (2020). Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis. Insect Molecular Biology, 29(1), 56–65.*

Harvey White | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Harvey White | Medicine and Dentistry | Best Researcher Award

Health New Zealand - The Health Network | New Zealand

Author Profile

Scopus

Orcid 

Early Academic Pursuits

Prof. Harvey White’s journey into medicine began with a strong academic foundation that laid the groundwork for his pioneering career in cardiology. His advanced studies culminated in a Doctorate of Science from the University of Otago, where his thesis explored the prognostic importance of cardiac volume and vessel patency in the context of thrombolytic therapy. This formative academic phase instilled in him both a scientific curiosity and a commitment to evidence-based medicine, shaping the direction of his future clinical and research endeavors.

Professional Endeavors

Over the decades, Prof. White has held leading positions in cardiology, serving as a cardiologist and Director of the Cardiovascular Research Unit at Auckland City Hospital, while also contributing as an Honorary Clinical Professor at the University of Auckland. His clinical practice has been marked by a dedication to advancing the treatment of acute coronary syndromes, dyslipidemia, and cardiovascular diseases in the elderly. Beyond hospital walls, his advocacy for patient-centered care and public health initiatives has reinforced his reputation as both a clinician and a community leader.

Contributions and Research Focus

Prof. White has made remarkable contributions in areas such as antithrombotic therapy, the universal definition of myocardial infarction, and biomarker development for acute coronary syndromes. His investigations into lipid-lowering therapies, genetic markers, and cardiovascular outcomes have influenced guidelines and shaped clinical practice worldwide. He has consistently emphasized the integration of clinical trials, translational research, and collaborative studies, ensuring that his findings benefit both scientific communities and patients directly.

Accolades and Recognition

A highly cited researcher, Prof. White’s prolific publication record—spanning books, book chapters, peer-reviewed articles, and clinical guidelines—has earned him recognition among the world’s most influential scientific minds. He has been honored with prestigious awards, including the Prince Mahidol Award for Medicine, fellowship titles from leading cardiology societies, and multiple recognitions for his research excellence and thought leadership. His standing among the top global experts in cardiology reflects not only his scholarly output but also his enduring influence on international medicine.

Impact and Influence

The global impact of Prof. White’s work is evident in both academia and clinical practice. His leadership in redefining myocardial infarction classifications has guided generations of cardiologists, while his advocacy for evidence-based practices has transformed patient care protocols. His influence extends to policy, having advised the World Health Organization on cardiovascular disease prevention and diabetes management in developing nations. As a mentor and educator, he has inspired countless medical professionals to pursue excellence in research and practice.

Legacy and Future Contributions

Prof. White’s legacy is firmly established in the annals of cardiovascular medicine, yet his ongoing contributions suggest that his influence is far from complete. His continuous research into emerging therapies, his role in international collaborations, and his commitment to bridging scientific advancements with real-world healthcare challenges ensure that his impact will continue to grow. By championing innovation while prioritizing patient welfare, he sets a standard for the future of cardiology.

Publications

Article: Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Authors: Harvey D. White, Sean M. O’Brien, William E. Boden, Stephen E. Fremes, Sripal Bangalore, Harmony R. Reynolds, Gregg W. Stone, Ziad A. Ali, Neeraj Parakh, Jose Luis Lopez-Sendon, et al.
Journal: American Heart Journal
Year: 2025

Article: Great Debate: the universal definition of myocardial infarction is flawed and should be put to rest
Authors: Juan-Carlos Kaski, Christian Mueller, Harvey White, Pedro Lopez-Ayala, Ranil de Silva
Journal: European Heart Journal (Other publication type)
Year: 2025

Article: Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Authors: C. Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White, Serge Korjian, John H. Alexander, A. Michael Lincoff, Mark Heise, Bronwyn A. Kingwell, et al.
Journal: European Heart Journal
Year: 2024

Article: Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Authors: Andrew P. DeFilippis, J. Dawn Abbott, Brandon M. Herbert, Marnie H. Bertolet, Bernard R. Chaitman, Harvey D. White, Andrew M. Goldsweig, Tamar S. Polonsky, Rajesh Gupta, Caroline Alsweiler, et al.
Journal: Circulation
Year: 2024

Article: Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis
Authors: Rajan Rehan, Sohaib Virk, Christopher C. Y. Wong, Freda Passam, Jamie Layland, Anthony Keech, Andy Yong, Harvey D. White, William Fearon, Martin Ng
Journal: Heart
Year: 2024

Conclusion

Prof. White’s biography is a testament to the profound difference that one individual can make in shaping modern medicine. His achievements reflect not only a personal dedication to research and patient care but also a broader vision for global cardiovascular health. His legacy, defined by innovation, leadership, and compassion, will inspire future generations of clinicians and researchers to carry forward the mission of improving lives through science and medicine.

Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assist. Prof. Dr. Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Carol Davila University of Medicine and Pharmacy | Romania

Author Profile

Scopus

Orcid

Google Scholar

🌱 Early Academic Pursuits

Dr. Narcis Valentin Tănase began his academic journey at the “Zinca Golescu” Theoretical High School in Pitești, graduating in 1991. He then pursued his medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, graduating in 1997 as a Doctor of Medicine 🎓. His commitment to continuous learning is reflected in further postgraduate training and specialization courses both in Romania and abroad.

🩺 Professional Endeavors

Since 2008, Dr. Tănase has been serving as a Consultant in Anesthesia and Intensive Care at the "Dr. Carol Davila" Central Military Emergency University Hospital in Bucharest. He also holds a position as an Assistant Professor at the Carol Davila University of Medicine and Pharmacy in the Department of Anesthesia and Intensive Care III. His earlier career includes roles as a medical resident and specialist in the same institution, showcasing a deep-rooted commitment to intensive care medicine over more than two decades.

🔬 Contributions and Research Focus

Dr. Tănase’s scientific research revolves around anesthesia, intensive care, pain management, and perioperative medicine. He has acted as Principal Investigator in notable international studies like PAIN OUT and the European Observational Study on Chronic Post-Surgical Pain. He has co-authored and authored numerous indexed scientific publications, covering complex case studies, anesthetic techniques like TIVA-TCI, and pain modulation strategies. He has also contributed to several medical textbooks and conference proceedings .

His involvement in over 20 national and international trials, workshops, and multicenter research programs underscores a dedication to evidence-based practice and advancing critical care medicine.

🏆 Accolades and Recognition

Dr. Tănase has been decorated with some of Romania’s most prestigious medical honors for military professionals:

  • Knight of the Order of Sanitary Merit (2010) 🛡️

  • Officer of the Order of Sanitary Merit (2021) 🎖️

  • Commander of the Order of Sanitary Merit (2024) 🏅

These awards reflect not only his clinical excellence but also his service to the military medical system in Romania.

🌍 Impact and Influence

Dr. Tănase has significantly shaped the Romanian intensive care landscape. As Coordinator of Transplant Programs at the Central Military Hospital (2014–2024), he contributed to life-saving procedures and the development of transplant infrastructure. He has organized and chaired several major congresses including the 16th Congress of the Balkan Military Medical Committee. Additionally, his role as President of the Hospital’s Ethics Committee since 2023 affirms his leadership in institutional governance.

His teaching activities, including national symposiums and international workshops, position him as a leading mentor in critical care and anesthesiology .

🌟 Legacy and Future Contributions

As a passionate educator and researcher, Dr. Narcis Valentin Tănase continues to shape the future of anesthesia and intensive care in Romania and beyond. His ongoing doctoral studies, editorial contributions to indexed journals, and mentorship roles ensure a growing legacy of scientific excellence, innovation, and ethical clinical practice. His vision includes refining protocols for postoperative care, enhancing pain management techniques, and expanding international collaboration in clinical research 🚀.

Publications

📄 A Clinical Comparative Study of Schnider and Eleveld Pharmacokinetic–Pharmacodynamic Models for Propofol Target-Controlled Infusion Sedation in Drug-Induced Sleep Endoscopy
Authors: Narcis Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Dan Corneci, Catalina Voiosu, Andreea Rusescu, Cristian Cobilinschi, Camelia Stanciu Găvan, Viorel Zainea
Journal: Biomedicines
Year: 2025

📄 Study of Two Sedative Protocols for Drug-Induced Sleep Endoscopy: Propofol versus Propofol-Remifentanil Combination, Delivered in Target-Controlled Infusion Mode
Authors: Narcis-Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Cristian Cobilinschi, Madalina Dutu, Dan Corneci, Viorel Zainea
Journal: Medicina
Year: 2024

📄 Clinical Characteristics and Factors Associated with ICU Mortality During the First Year of the SARS-Cov-2 Pandemic in Romania: A Prospective, Cohort, Multicentre Study of 9000 Patients
Authors: Bubenek-Turconi S.I., Andrei S., Valeanu L., Stefan M.-G., Grigoras I., Copotoiu S., Bodolea C., Tomescu D., Popescu M., Filipescu D., et al.
Journal: European Journal of Anaesthesiology
Year: 2023

📄 Cervico-Thoracic Air Collections in COVID-19 Pneumonia Patients – Our Experience and Brief Review
Authors: C.E. Nistor, C.S. Gavan, D. Pantile, N.V. Tănase, A. Ciuche
Journal: Chirurgia (Romania)
Year: 2022

📄 Individualized Surgical Antibiotic Prophylaxis – Why, When, and How?
Authors: Dan Corneci, Ligia I. Torsin, Cristina R. Filimon, Narcis V. Tănase, Emanuel Moisa, Silvius I. Negoita
Journal: Romanian Journal of Military Medicine
Year: 2022

Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Published on by Book of Award

Dr. Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Shanghai Sixth People's Hospital | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Jin-Lu Huang’s academic journey reflects a steadfast dedication to the pharmaceutical sciences. He began his higher education at Lin Yi University, earning a Bachelor’s Degree in Life Science in 2004. He then pursued a Master’s Degree in Microbiology and Biochemical Pharmacy at the China Pharmaceutical University, graduating in 2007. Driven by a passion for research, Dr. Huang completed his PhD in Pharmacy at Shanghai Jiao Tong University in 2012, laying the foundation for a research-intensive career in pharmacology and clinical applications.

💼 Professional Endeavors

Since July 2012, Dr. Huang has served as a Pharmacist at the Department of Pharmacy, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His clinical expertise is complemented by an earlier role (2007–2008) as a Researcher at Shanghai Hengrui Pharmaceutical Co., Ltd., where he was involved in cutting-edge drug development and R&D processes.

🔬 Contributions and Research Focus

Dr. Huang's research spans ionomic metabolism, neuropathic and bone cancer pain, drug-induced side effects, and hospital pharmaceutical practices. His work often bridges basic pharmacological science with clinical application, focusing on pain modulation, calcium signaling pathways, and drug safety evaluation. He has authored over 20 peer-reviewed articles, including high-impact studies on analgesic mechanisms, store-operated calcium entry in neuropathy, and bone cancer pain ionomics. Notably, many of his papers explore pain at a molecular level, offering insights into sphingosine-1-phosphate receptors, ionomic profiles, and nuclear receptor signaling pathways.

🏅 Accolades and Recognition

Dr. Huang is a respected member of several leading professional societies including the Chinese Pharmacological Society, the International Union of Basic and Clinical Pharmacology, and the British Pharmacological Society. His extensive publication record, both as a lead author and co-investigator, reflects international recognition and collaboration. His research has appeared in journals like FEBS Open Bio, Pain, Scientific Reports, and Pharmaceutical Biology.

🌏 Impact and Influence

Dr. Huang's work has contributed significantly to the pharmacological understanding of chronic pain, particularly in the context of bone cancer and neuropathy. His analyses using bioinformatics tools like GoPubMed and his contributions to visualizing research trends have informed policy and practice in hospital pharmacy and drug safety evaluation. His studies are frequently referenced by fellow researchers and clinicians dealing with oncology-related pain and pharmaceutical practices in hospitals.

🔮 Legacy and Future Contributions

As a bridge between clinical pharmacy and laboratory research, Dr. Jin-Lu Huang is poised to leave a lasting legacy in translational pharmacology. With ongoing investigations into neuroinflammation, analgesic mechanisms, and metabolic responses to drug therapies, he continues to shape the future of personalized and precision medicine in pain management. His commitment to advancing both theoretical insights and clinical practices ensures that his contributions will benefit patients and healthcare systems for years to come.

 

Publications

  • 📄Involvement of ionomic metabolism of both the cerebrospinal fluid and the spinal cord in the analgesic efficacy of matrine in rats
    Authors: Huang JL, Tang CY, Fu Y, Wan LL, Li J, Sun XP, Hu JL, Zhang YY, Qu LY, Fu MJ, Zhang YY, Ma L, Guo C, Chen JG
    Journal: Pharmaceutical Biology
    Year: 2025
  • 📄Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia
    Authors: Chen L, Zhang H, Chi M, Guo C, Yang Q
    Journal: Molecular Nutrition and Food Research
    Year: 2024
  • 📄Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
    Authors: Wang Q, Duan D, Luo C, Yang S, Ma L
    Journal: Annals of Medicine
    Year: 2024
  • 📄Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain
    Authors: Huang JL, Chen JG, Ma L, Zhu XY, Wan LL, Li XY, Guo C
    Journal: Journal of Pain Research
    Year: 2024
  • 📄Store-operated calcium entry mediates hyperalgesic responses during neuropathy
    Authors: Wang W, Wang Q, Huang JL, Li H, Li F, Li X, Liu R, Xu M, Chen J, Mao Y, Ma L
    Journal: FEBS Open Bio
    Year: 2023

 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Bojan Miletic | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Bojan Miletic | Medicine and Dentistry | Best Researcher Award

University of Rijeka | Croatia

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications

  • 📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population

      • Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
      • Journal: Medicina
      • Year: 2025

  • 📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge

      • Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
      • Journal: Travel Medicine and Infectious Disease
      • Year: 2025

  • 📄The Physical Activity and Dietary Habits of Nursing Students

    • Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
    • Journal: Medical Research Archives
    • Year: 2024

  • 📄Virtual reality in the education of instrumentation techniques for nurses/technicians

    • Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
    • Journal: World of Health
    • Year: 2024

  • 📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar

    • Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
    • Event: 27th Congress of Emergency Medicine with International Participation
    • Year: 2024

 

Shinya Watanabe | Neuroscience | Best Research Award

Published on by Book of Award

Assist. Prof. Dr. Shinya Watanabe | Neuroscience | Best Research Award

University of Tsukuba | Japan 

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Shinya Watanabe’s academic journey began at Chiba University’s Department of Pharmaceutical Sciences. However, driven by a passion for medicine, he transitioned to the University of Tsukuba, earning a Bachelor’s degree in Medicine in 2005 and later a Ph.D. in Medicine in 2015. His diverse educational pursuits also include a specialized program in Medical Innovation Strategy at Chiba University, reflecting his commitment to integrating clinical expertise with innovative healthcare solutions.

Professional Endeavors 🩺

Dr. Watanabe’s illustrious medical career spans over two decades, marked by extensive hands-on experience across several leading hospitals in Japan. Starting as a resident at Tsukuba University Hospital, he later specialized as a neurosurgeon in institutions like Hitachi General Hospital and Tsukuba Medical Center. His tenure with the Pharmaceuticals and Medical Devices Agency (PMDA) between 2017 and 2020 saw him influencing drug, device, and regenerative medicine reviews, underscoring his role as a key figure in Japan’s medical regulatory landscape. Currently, he serves as a Lecturer at the University of Tsukuba’s Faculty of Medicine, contributing to both clinical practice and medical education.

Contributions and Research Focus 🔬

Dr. Watanabe’s research spans a variety of critical areas, including neurotrauma, cancer treatment, and dementia. His expertise has been certified by prestigious bodies such as the Japan Neurosurgical Society and the Japanese Society of Dementia. A thought leader in his field, Dr. Watanabe has actively developed innovative treatments, such as headache management techniques, and remains a sought-after expert in advancing medical technology and therapeutic strategies.

Accolades and Recognition 🏆

Dr. Watanabe’s exceptional contributions have been celebrated with numerous awards, such as the 12th Nose Award and the Research Encouragement Award from the Japanese Society for Diencephalo-Pituitary Tumors. In 2020, his groundbreaking interdisciplinary work earned him the Joyo Bank Award, highlighting his ability to bridge clinical practice with innovative technologies.

Impact and Influence 🌍

Through his extensive clinical and academic roles, Dr. Watanabe has shaped the practice of neurosurgery and medical device innovation in Japan. His contributions to the PMDA and ARO Council have had far-reaching effects, ensuring that healthcare products meet rigorous safety and efficacy standards. He has also inspired future generations of medical professionals through his dedication to education at the University of Tsukuba.

Legacy and Future Contributions 🌟

Dr. Watanabe’s legacy lies in his ability to blend clinical precision with innovation. As a pioneer in interdisciplinary research, he continues to push the boundaries of medical science, ensuring a brighter future for patients worldwide. His ongoing contributions to neuroscience, cancer treatment, and dementia care are set to redefine the standards of modern medicine, establishing him as a beacon of excellence in healthcare. With a career characterized by unwavering dedication and transformative achievements, Assist. Prof. Dr. Shinya Watanabe embodies the spirit of medical innovation and compassion.

 

Publications

📄"A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology"

  • Author: Watanabe, S.; Shibata, Y.; Ishikawa, E.
  • Journal: Neurology International
  • Year: 2024

📄"A Retrospective Cohort Study of Stereotactic Radiosurgery for Vestibular Schwannomas: Comparison of Two Age Groups (75 Years or Older vs. 65–74 Years)"

  • Author: Watanabe, S.; Yamamoto, M.; Aiyama, H.; Akutsu, H.; Ishikawa, E.
  • Journal: Surgical Neurology International
  • Year: 2024

📄"Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2024

📄"Empirical Myoelectric Feature Extraction and Pattern Recognition in Hemiplegic Distal Movement Decoding"

  • Author: Anastasiev, A.; Kadone, H.; Marushima, A.; Matsumaru, Y.; Ishikawa, E.
  • Journal: Bioengineering
  • Year: 2023

📄"Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2023

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022